Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

'Kiss' hormone to give new hope to infertile women

22 March 2009

By Sarah Pritchard

Appeared in BioNews 500

A group of scientists at Imperial College London have found that administration of the recently discovered protein 'kisspeptin' could 'restore fertility' for some women and form the basis for a new fertility treatment.

The findings of the research, presented at the annual Society for Endocrinology BES (British Endocrine Societies) meeting in Yorkshire and led by Dr Waljit Dhillo, showed that after receiving kisspeptin, women whose infertility was caused by the cessation of their menstrual periods began producing reproductive hormones again. Having discovered two years ago that kisspeptin treatment stimulated reproductive hormone release in fertile women, Dr Dhillo turned his research to infertile women.

Kisspeptin is produced during puberty and triggers the release of sex hormones, without which humans and animals would miss puberty and remain sexually immature. Conversely, over-activation of kisspeptin's receptor GPR54 causes early onset puberty.

The study at Imperial College included ten women who were not menstruating, five of whom were given kisspeptin, and the other five were given saline solution. Blood tests of those who received the kisspeptin revealed that there had been a 48-fold increase in the production of lutenising hormone, and a 16-fold increase in follicle stimulating hormone, both key sex hormones for ovulation and fertility. These results were far higher than those previously gathered for fertile women.

'This is a very exciting result and suggests that kisspeptin treatment could restore reproductive function in women with low sex hormone levels. Our future research will focus on determining the best protocol for repeated administration with the hope of developing a new therapy for infertility' said Dr Dhillo.

Professor Richard Anderson, a fertility expert from the University of Edinburgh said that the research held the promise of a more subtle way of treating women whose reproductive systems had 'shut down'. Where most current treatments involve the direct stimulation of a woman's ovaries which carries a risk of multiple births and side effects, kisspeptin would potentially address the underlying problem and maintain the body's own protective regulatory mechanisms. Professor Anderson believes the hormone 'may well become a mainstream part of therapy'.

SOURCES & REFERENCES
Wellcome Trust | 17 March 2009
 
BBC News Online | 17 March 2009
 
'Kiss' therapy infertility hope
Associated Press | 17 March 2009
 
Los Angeles Times | 16 March 2009
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

28 July 2014 - by Purvi Shah 
Twelve healthy babies have been born after trials of a hormone treatment called kisspeptin-54 that has been hailed as a safer way to mature women's eggs prior to IVF...
24 June 2013 - by Siobhan Chan 
A new IVF hormone treatment that has resulted in the birth of a baby boy could make IVF less risky, scientists report...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation